If you are still having problems viewing this message, please click here for additional help.

Oncogene
 
TABLE OF CONTENTS

Volume 37, Issue 20

In this issue
Article
Brief Communications
Also new
AOP
 

Article

Targeting UDP-a-d-glucose 6-dehydrogenase inhibits glioblastoma growth and migration

Olutobi Oyinlade, Shuang Wei, Bachchu Lal, John Laterra, Heng Zhu et al.

Oncogene 2018 37 :2615 - 2629; February 26, 2018; 10.1038/s41388-018-0138-y

 

Abstract | Full Text

Functional screening of FGFR4-driven tumorigenesis identifies PI3K/mTOR inhibition as a therapeutic strategy in rhabdomyosarcoma

Timothy McKinnon, Rosemarie Venier, Marielle Yohe, Sivasish Sindiri, Berkley E. Gryder et al.

Oncogene 2018 37 :2630 - 2644; February 28, 2018; 10.1038/s41388-017-0122-y

 

Abstract | Full Text

How asbestos drives the tissue towards tumors: YAP activation, macrophage and mesothelial precursor recruitment, RNA editing, and somatic mutations

Hubert Rehrauer, Licun Wu, Walter Blum, Lazslo Pecze, Thomas Henzi et al.

Oncogene 2018 37 :2645 - 2659; March 06, 2018; 10.1038/s41388-018-0153-z

 

Abstract | Full Text

LINC01410-miR-532-NCF2-NF-kB feedback loop promotes gastric cancer angiogenesis and metastasis

Jia-Xing Zhang, Zhen-Hua Chen, Dong-Liang Chen, Xiao-Peng Tian, Chen-Yuan Wang et al.

Oncogene 2018 37 :2660 - 2675; February 27, 2018; 10.1038/s41388-018-0162-y

 

Abstract | Full Text

HIF1a drives chemokine factor pro-tumoral signaling pathways in acute myeloid leukemia

Amina M. Abdul-Aziz, Manar S. Shafat, Yu Sun, Christopher R. Marlein, Rachel E. Piddock et al.

Oncogene 2018 37 :2676 - 2686; February 28, 2018; 10.1038/s41388-018-0151-1

 

Abstract | Full Text

The novel BET bromodomain inhibitor BI 894999 represses super-enhancer-associated transcription and synergizes with CDK9 inhibition in AML

Daniel Gerlach, Ulrike Tontsch-Grunt, Anke Baum, Johannes Popow, Dirk Scharn et al.

Oncogene 2018 37 :2687 - 2701; March 01, 2018; 10.1038/s41388-018-0150-2

 

Abstract | Full Text

USP27-mediated Cyclin E stabilization drives cell cycle progression and hepatocellular tumorigenesis

Ling Dong, Le Yu, Chunrong Bai, Liu Liu, Hua Long et al.

Oncogene 2018 37 :2702 - 2713; March 02, 2018; 10.1038/s41388-018-0137-z

 

Abstract | Full Text

EZH2 regulates neuroblastoma cell differentiation via NTRK1 promoter epigenetic modifications

Zhenghao Li, Hisanori Takenobu, Amallia Nuggetsiana Setyawati, Nobuhiro Akita, Masayuki Haruta et al.

Oncogene 2018 37 :2714 - 2727; March 06, 2018; 10.1038/s41388-018-0133-3

 

Abstract | Full Text

HPSE enhancer RNA promotes cancer progression through driving chromatin looping and regulating hnRNPU/p300/EGR1/HPSE axis

Wanju Jiao, Yajun Chen, Huajie Song, Dan Li, Hong Mei et al.

Oncogene 2018 37 :2728 - 2745; March 07, 2018; 10.1038/s41388-018-0128-0

 

Abstract | Full Text

Brief Communications

LIN28B enhanced tumorigenesis in an autochthonous KRASG12V-driven lung carcinoma mouse model

Lydia Meder, Katharina K├Ânig, Felix Dietlein, Iris Macheleidt, Alexandra Florin et al.

Oncogene 2018 37 :2746 - 2756; March 05, 2018; 10.1038/s41388-018-0158-7

 

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature